@article{d51514a5b4124bc48147c27f73c19dc2,
title = "A tool for safer prescribing in vulnerable adults: The continuing development of the Medichec app and website",
abstract = "Aims and method Adverse effects are a common concern when prescribing and reviewing medication, particularly in vulnerable adults such as older people and those with intellectual disability. This paper describes the development of an app giving information on side-effects, called Medichec, and provides a description of the processes involved in its development and how drugs were rated for each side-effect. Medications with central anticholinergic action, dizziness, drowsiness, hyponatraemia, QTc prolongation, bleeding and constipation were identified using the British National Formulary (BNF) and frequency of occurrence of these effects was determined using the BNF, product information and electronic searches, including PubMed. Results Medications were rated using a traffic light system according to how commonly the adverse effect was known to occur or the severity of the effect. Clinical implications Medichec can facilitate access to side-effects information for multiple medications, aid clinical decision-making, optimise treatment and improve patient safety in vulnerable adults.",
keywords = "anticholinergic, dementia, medication, Medichec, side-effects",
author = "Delia Bishara and Sahar Riaz and Justin Sauer and Christoph Mueller and Siobhan Gee and David Taylor and Wilcha, {Robyn Jenia} and Millie Edwards and Nirja Beehuspoteea and Mallia, {Anne Marie Bonnici} and Jennifer Brook and Bharathi Balasundaram and Daniel Harwood and Nicola Funnell and Andre Strydom and Robert Stewart",
note = "Funding Information: R.S. and C.M. are part-funded by the National Institute for Health and Care Research (NIHR) Maudsley Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London. R.S. is additionally part-funded by (a) the NIHR Applied Research Collaboration South London (NIHR ARC South London) at King's College Hospital NHS Foundation Trust; (b) UK Research and Innovation (UKRI) – Medical Research Council through the DATAMIND HDR UK Mental Health Data Hub (MRC reference: MR/W014386); (c) the UK Prevention Research Partnership (Violence, Health and Society; MR-VO49879/1), an initiative funded by UKRI Councils, the Department of Health and Social Care (England) and the UK devolved administrations, and leading health research charities. A.S. holds grants from the Medical Research Council (grant MR/S011277/1, MR/S005145/1 and MR/R024901/1), European Commission (H2020 SC1 Gene overdosage and comorbidities during the early lifetime in Down Syndrome GO-DS21- 848077), NIHR, and the LeJeune Foundation. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. Publisher Copyright: Copyright {\textcopyright} The Author(s), 2023. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists.",
year = "2023",
month = sep,
day = "6",
doi = "10.1192/bjb.2023.71",
language = "English",
journal = "BJPsych Bulletin",
issn = "2056-4694",
publisher = "Royal College of Psychiatrists",
}